But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...
When prescribing glucagon-like peptide 1 (GLP-1) medications, many physicians prefer tirzepatide over the more well-known semaglutide due to its superior efficacy in weight loss and A1c reduction.
With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...
Madrigal’s Rezdiffra has launched a new MASH market, but ‘tremendous change’ is on the horizon
With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
Like semaglutide, this is one of the diabetes drugs for weight loss that’s injected once weekly. Tirzepatide is the active ingredient in the brand-name drugs Mounjaro® and Zepbound®.
Semaglutide, like tirzepatide, is injected under the skin and is intended to be sterile. Injecting a "non-sterile drug intended to be sterile may result in serious and potentially life-threatening ...
A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's ( NVO) semaglutide and Eli Lilly's ( LLY) tirzepatide could also be effective in tackling Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback